Delphi Medical Introduces Clinical Communication Software
Release Date: January 04, 2005
TROY, Mich. - Delphi Medical Systems, a subsidiary of Delphi Corp. (NYSE: DPH), signed a licensing agreement with Caretools, a clinical information systems company, to co-develop and sell software supporting independent, remote communication between physicians and their patients' health status.
The agreement provides exclusive worldwide rights for Delphi Medical Systems to market, sell and distribute software that will facilitate short- and long-range digital communication between a hand-held personal desk assistant and medical devices to enable monitoring of medical devices such as I.V. pumps, vital signs monitors and respiratory devices. With their hand-held PDA or from their PC, health care practitioners will be able to start, stop or alter a patient's medication delivery or therapy or monitor their vital signs, remotely.
"These software packages will make Delphi Medical Systems the only provider of easy-to-use handheld devices that can monitor and even control from a remote location several different medical devices," said Christophe Sevrain, Delphi Medical Systems managing director. "The combination of Delphi Medical's devices with this software application enhancement helps create a cost and time saving solution for health care providers, allowing them to optimize their resources and dedicate them where patients need it most."
A recently announced licensing agreement with Zoe Medical gave Delphi Medical worldwide rights to manufacture, market, distribute and sell hospital and alternate site vital signs patient monitors worldwide. These monitors measure and provide readings of blood pressure, electrocardiogram, temperature, weight, pulse rate, blood oxygen level and even glucose levels. Additionally, Delphi's IVantage, an intravenous pump, will also be able to be programmed and monitored from a remote location.
The new software will enable all this patient information to be transmitted directly to a nurse's station computer or a hand-held PDA whether the patient is in a hospital, at home, or at an extended care facility anywhere in the world. This PDA will also feature the existing underlying software capabilities available in the Caretool's PDA software such as point and click customizable menus for quick note entry and complete electronic medical record system. It may also receive signals from medical devices developed by other companies.
"We are excited to collaborate with a company committed to providing advanced technology in health care," said Thomas Giannulli, MD, president, Caretools. "Our licensing agreement with Delphi Medical enhances PocketChart's reach to medical devices, enhancing its marketability."
The software can be used with any Windows CE-based PDA with global reach for easy remote use. A PDA using the software can also be synchronized with a desktop, enabling doctors and nurses to continuously update, view, exchange and print patients' information.
"This agreement is expected to strengthen our presence in the medical device market and help reduce costs while enhancing the quality of health care through increased efficiencies," Sevrain said.
About CareTools
CareTools is a company dedicated to providing leading-edge mobile clinical solutions to its customers. CareTools was founded by a pioneering physician and veteran executive from the field of clinical information systems. CareTools products are the most successful products in their category and are the "Gold Standard" with respect to hand-held physician workflow.
About Delphi Medical Systems
Delphi Medical Systems is a world-class provider of technology, products, and product development and manufacturing for Dialysis, Infusion, Respiratory Care, Vital Signs Monitoring and Power Mobility. Its capabilities stem from Delphi's vast technology base, product development expertise and manufacturing excellence.
For more information on Delphi Medical Systems, please visit its website at: www.delphimedical.com.
FORWARD-LOOKING STATEMENT
All statements contained or incorporated in this press release which address operating performance, events or developments that we expect or anticipate may occur in the future (including statements relating to future sales or earnings expectations, volume growth, awarded sales contracts or statements expressing general optimism about future operating results) are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are made on the basis of management's current views and assumptions with respect to future events. Important factors, risks and uncertainties which may cause actual results to differ from those expressed in our forward-looking statements are discussed in detail in our filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2003. In particular, the achievement of projected levels of royalties and profit margins over a licensing agreement will depend in part on customer demand which may be affected by, among other things, uncertainty of product development and manufacturing, uncertainty about obtaining and maintaining FDA regulatory clearances and the timing of receiving marketing clearances, uncertainty relating to third party reimbursement, ability to convince health care professionals and third party payers of the medical and economic benefits of the licensed products, changes in general economic conditions, and changes in our ability to satisfy service, technology, quality and other requirements. Delphi does not intend or assume any obligation to update any of these forward-looking statements.
Luce Rubio
luce.rubio@delphi.com
[1] 248.813.2618
